Culture‐proven late‐onset sepsis · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Bronchopulmonary dysplasia · promoting growth and development in very low birth weight infants receiving human milk
It is very uncertain whether targeted or adjustable individualized fortification changes bronchopulmonary dysplasia compared with standard non‐individualized fortification (very low certainty).
1 finding from 1 review
Retinopathy of prematurity · promoting growth and development in very low birth weight infants receiving human milk
It is very uncertain whether targeted or adjustable individualized fortification changes retinopathy of prematurity, any compared with standard non‐individualized fortification (very low certainty).
1 finding from 1 review
Presence of osteopenia · promoting growth and development in very low birth weight infants receiving human milk
It is very uncertain whether targeted or adjustable individualized fortification changes osteopenia compared with standard non‐individualized fortification (very low certainty).
1 finding from 1 review
Smoking cessation · people who smoke
Individual counselling leads to higher smoking cessation at longest compared with minimal contact control (high certainty).
2 findings from 1 review
Tooth- and tissue-supported removable partial denture: dual-impression technique with a different material vs An alternative dual-impression technique with a different material
Outcome not reported · Partially edentulous people requiring a tooth- and tissue-supported (distal-extension) removable partial denture
The review found no eligible studies for this question.
1 finding from 1 review
Successful treatment of exacerbation: number of participants cured. Outcome assessed on day 42 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes successful treatment of exacerbation: number of participants cured.… compared with oral monotherapy (very low certainty).
1 finding from 1 review
Successful treatment of exacerbation: number of participants with P aeruginosa eradication. Outcome assessed on day 21 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes successful treatment of exacerbation: number of participants with P… compared with oral monotherapy (very low certainty).
1 finding from 1 review
Serious adverse events. Outcome assessed on day 42 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes serious adverse events. Outcome assessed on day 42 compared with oral monotherapy (very low certainty).
1 finding from 1 review
Relapse · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes treatment response: relapse (day 42). Outcome assessed on day 42 compared with oral monotherapy (very low certainty).
1 finding from 1 review
Microbiological response: eradicated. Outcome assessed on day 21 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes microbiological response: eradicated. Outcome assessed on day 21 compared with oral monotherapy (very low certainty).
1 finding from 1 review
Hospital admissions · bronchiectasis
1 finding from 1 review
Death · bronchiectasis
1 finding from 1 review
Quality of life · bronchiectasis
1 finding from 1 review
Overall survival: Median length of · women with advanced EOC after primary IDS
It is very uncertain whether residual disease (RD) > 0 cm changes overall survival: Median length of compared with NMRD (very low certainty).
1 finding from 1 review
Progression‐free survival · women with advanced EOC after primary IDS
It is very uncertain whether residual disease (RD) > 0 cm changes progression‐free survival: Median length of compared with NMRD (very low certainty).
1 finding from 1 review
Treatment completers ‐ Individual‐based intervention · Individuals with post‐traumatic stress disorder and comorbid substance use disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severity of PTSD symptoms · Individuals with post‐traumatic stress disorder and comorbid substance use disorder
2 findings from 1 review
Drug or alcohol use, or both following treatment completion ‐ Individual‐based intervention · Individuals with post‐traumatic stress disorder and comorbid substance use disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found